Skip to content
Recall Observatory FDA recall evidence

Device product

13C-Spirulina Gastric Emptying Breath Test (GEBT) - Product Usage: intended for use in the measurement of the rate of gastric emptying of solids and as an aid in the diagnosis of delayed gastric emptying (gastroparesis) in adult humans who are symptomatic for gastroparesis.

Z-1128-2021

January 08, 2021

Class II

Product summary

Firm
Cairn Diagnostics
Event
Event 87186
Status
Terminated
Classification
Class II
Quantity
103 kits
Official record key
device-enforcement:Z-1128-2021

Official wording

Reason: Potential for false negative diagnosis of gastroparesis. Certain GEBT kits containing 13C-Spirulina elicit unusually high 13CO2-excretion rates

Code information: Lot Codes: K021-021R, K021-022

Distribution pattern: US Nationwide distribution in the states of GA, NY, MI, CA, KS, NC.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Potential for false negative diagnosis of gastroparesis. Certain GEBT kits containing 13C-Spirulina elicit unusually high 13CO2-excretion rates

Field note

Send feedback

We'll only use this to respond to your feedback.